Immunoregulatory Effects of Phospholipase A₂ (PLA₂) on the Proliferation of Human Lymphocytes

References

• Wolfe L S. Eicosanoids: Prostaglandins, thromboxanes, leukotrienes, and other derivatives of car-bon-20 unsaturated fatty acids. J Neurochem 1982; 38: 1–14
   PubMed Web of Science ®Google Scholar
• Gonzalez-Buritica H, Khamashta M A., Hughes G RV. Synovial fluid phospholipase A2s and inflammation. Ann Rheum Dis 1989; 48: 26–79
   Google Scholar
• Vadas P, Pruzanski W. Role of extracellular phospholipase A2 in inflammation. Advances in Inflammation Research, I Otterness, R Capetola, S Wong. Raven Press, New York 1984; Vol 7: 51–9
   Google Scholar
• Kuehl F A., Jr, Egan R W. Prostaglandins, arachidonic acid and inflammation. Science 1980; 210: 978–84
   PubMed Web of Science ®Google Scholar
• Palmblad J, Malmsten C L., Uden A-M, Radmark O, Engstedt L. Samuelsson B. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 1981; 58: 658–61
   PubMed Web of Science ®Google Scholar
• Vadas P, Wasi S, Movat H Z., Hay J B. Extracellular phospholipase A2 mediates inflammatory hyperemia. Nature 1981; 293: 583–5
   PubMed Web of Science ®Google Scholar
• Vadas P. The efficacy of anti-inflammatory agents with respect to extracellular phospholipase A2 activity. Life Science 1982; 30: 155–62
   PubMedGoogle Scholar
• Nevalainen J J. The role of phospholipase A in acute pancreatitis. Scand J Gastroenterol 1980; 15: 641–50
   PubMed Web of Science ®Google Scholar
• Mero N, Schroder T, Tenhunen R, Lempinen M. Serum phospholipase A2, imraunoreactive trypsin, and trypsin inhibitors during human acute pancreatitis. Scand J Gastroenterol 1982; 17: 413–6
   PubMed Web of Science ®Google Scholar
• Vadas P, Hay J B. Involvement of circulating phospholipase A2 in the pathogenesis of the hemody-namic changes in endotoxin shock. Can J Physiol Pharmacol 1983; 61: 561–6
   PubMed Web of Science ®Google Scholar
• Vadas P, Pruzanski W, Stefanski E, Sternby B, Mustard R, Bohnen J, Fraser I, Farewell V, Bombardier C. Pathogenesis of hypotension in septic shock: Correlation of circulating phospholipase A2 levels with circulatory collapse. Crit Med Care 1988; 16: 1–7
   PubMed Web of Science ®Google Scholar
• Vadas P, Hay J B. The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions. Am J Pathol 1982; 107: 285–91
   PubMedGoogle Scholar
• Pruzanski W, Vadas P, Stefanski E, Urowitz M B. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis: Its possible role as a proinflammatory enzyme. J Rheumatol 1985; 12: 211–6
   PubMed Web of Science ®Google Scholar
• Stefanski E, Pruzanski W, Sternby B, Vadas P. Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis. J Biochem 1986; 100: 1297–303
   PubMed Web of Science ®Google Scholar
• Bolin T, Heuman R, Sjodahl R, Tagesson C. Decreased lysophospholipase and increased phospholipase A2 activity in ileal mucosa from patients with Crohn's disease. Digestion 1984; 29: 55–9
   PubMedGoogle Scholar
• Forster S, Ilderton E, Summerly R, Yardley H J. The level of phospholipase A2 activity is raised in the uninvolved epidermis of psoriasis. Br J Dermatol 1983; 108: 103–5
   PubMed Web of Science ®Google Scholar
• Vadas P, Pruzanski W, Fornasier V, Kim J. Acute inflammation induced by intradermal and intra-articular injection of soluble PLA2. Arthritis Rheum 1986; 29: S37
   Google Scholar
• Shapiro H M., Natale P J., Kamentsky L A. Estimation of membrane potentials of individual lymphocytes by flow cytometry. Proc Natl Acad Sci USA 1979; 76: 5728–30
   PubMed Web of Science ®Google Scholar
• Vadas P. Elevated plasma phospholipase A2 levels: Correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med 1984; 104: 873–81
   PubMed Web of Science ®Google Scholar
• Pruzanski W, Vadas P, Fornasier V. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. J Invest Dermatol 1986; 86: 380–3
   PubMedGoogle Scholar
• Vadas P, Pruzanski W, Kim J, Fornasier V. The proinflammatory effect of intra-articular injections of soluble venom and human phospholipase A2. Am J Pathol 1989; 134: 807–11
   PubMedGoogle Scholar
• Zawalich W, Zawalich K. Effect of exogenous phospholipase A2 on insulin secretion from perfused rat islets. Diabetes 1985; 34: 471–6
   PubMedGoogle Scholar
• Betteridge A, Wallis M. Stimulation of anterior pituitary prostaglandin E content and somatotropin (growth hormone) synthesis by phospholipase A. Biochem J 1978; 176: 319–23
   PubMedGoogle Scholar
• Chi E Y., Henderson W R., Klebanoff S J. Phospholipase A2-induced rat mast cell secretion: Role of arachidonic acid metabolites. Lab Invest 1982; 47: 579–85
   PubMed Web of Science ®Google Scholar
• Marone G, Kagey-Sobotka A, Lichtenstein L M. Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro. Clin Immunol Immunopathol 1981; 20: 231–9
   PubMedGoogle Scholar
• Yawo H, Kuno M. How a nerve fiber repairs its cut end: Involvement of phospholipase A2. Science 1983; 222: 1351–2
   PubMed Web of Science ®Google Scholar
• Gramzow M, Schroder H C., Fritsche U, Kurelec B, Robitzki A, Zimmermann H, Friese K, Kreuter M H., Muller W EG. Role of phospholipase A2 in the stimulation of sponge cell proliferation by homologous lectin. Cell 1989; 59: 939–48
   PubMedGoogle Scholar
• Hoffman T, Hirata F, Bougnoux P, Fraser B A., Goldfarb R H., Herberman R B., Axelrod J. Phospho-lipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proc Natl Acad Sci USA 1981; 78: 3839–41
   PubMed Web of Science ®Google Scholar
• Hattori T, Hirata F, Hoffman T, Hizuta A, Herberman R B. Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein. J Immunol 1983; 131: 662–5
   PubMed Web of Science ®Google Scholar
• Carine K, Hudig D. Assessment of a role of phospholipase A2 and arachidonic acid metabolism in human natural cytotoxicity. Cell Immunol 1984; 87: 270–83
   PubMedGoogle Scholar
• Skouteris G G., Ord M G., Stocken L A. Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J Cell Physiol 1988; 135: 516–20
   PubMedGoogle Scholar
• Webb D R., Nowowiejski. Mitogen-induced changes in lymphocyte prostaglandin levels: A signal for induction of suppressor cell activity. Cell Immunol 1978; 41: 72–85
   PubMed Web of Science ®Google Scholar
• Stobo J D., Kennedy M S., Goldyne M E. Prostaglandin E modulation of the mitogenic response of human T cells: Differential response of T-cell subpopulations. J Clin Invest 1979; 64: 1188–95
   PubMed Web of Science ®Google Scholar
• Pruzanski W, Vadas P, Kim J, Jacobs H, Stefanski E. Phospholipase A2 activity associated with synovial fluid cells. J Rheumatol 1988; 15: 791–4
   PubMed Web of Science ®Google Scholar
• Marcus A J., Ullman H L., Safier L B. Lipid composition of subcellular particles of human platelets. J Lipid Res 1969; 10: 108–14
   PubMed Web of Science ®Google Scholar